Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma

Published:2013 Issue:3 Volume:54 Page:643
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Lee Kyong Joo¹,Yi Seung Woo¹,Chung Moon Jae¹,Park Seung Woo¹,Song Si Young¹²³,Chung Jae Bock¹,Park Jeong Youp¹

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

2. Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

3. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3349/ymj.2013.54.3.643

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of tumor marker kinetics and normalization during neoadjuvant chemotherapy for pancreatic cancer;Hepatobiliary Surgery and Nutrition;2024-04

2. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability;Annals of Surgical Oncology;2024-03-19

3. Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up;Hepatobiliary Surgery and Nutrition;2024-02

4. CA19-9 and CEA biosensors in pancreatic cancer;Clinica Chimica Acta;2024-02

5. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma;Journal of Surgical Oncology;2024-01-04